查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1241448

草銨膦的全球市場

Glufosinate
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

草銨膦的全球市場2030年之前達到45億美元

在COVID-19後改變的商務環境中，2022年24億美元的草銨膦的全球市場，2030年前將達到45億美元，在2022年～2030年預計將以年複合成長率8％增長。本報告所分析之市場區隔之一的基因改造年複合成長率將記錄8.4％，到分析期間結束時將達到34億美元。考慮疫情後的復甦，傳統市場領域今後8年的年複合成長率將修正為6.8％。

美國市場6億4,650萬美元，中國以年複合成長率11.8％增長

美國的草銨膦市場在2022年估算為6億4,650萬美元。作為世界第2大經濟大國的中國，在2022年～2030年年複合成長率預計將為11.8％，2030年前將達到11億美元的市場規模。其他熱門的地區市場有日本和加拿大，從2022年到2030年將各以4.2％和7.1％的速度成長。在歐洲市場中，德國以年複合成長率4.9％成長。

調查對像企業範例

  • Bayer AG
  • Bayer CropScience AG
  • Dow, Inc.
  • DuPont de Nemours, Inc.
  • Jiangsu Huangma Agrochemicals Co., Ltd.
  • Jiangsu Sevencontinent Green Chemical Co., Ltd.
  • LIER Chemical Co., Ltd.
  • Nufarm Limited
  • Syngenta AG
  • UPL Ltd.
  • Veyong(Hebei Veyong Bio-Chemical Co. Ltd)

目錄

第1章 調查手法

第2章 摘要整理

  • 市場概要
  • 主要企業
  • 市場趨勢與推動因素
  • 全球市場預測

第3章 市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 南美
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他南美國家
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東
  • 非洲

第4章 競爭

簡介目錄
Product Code: MCP12196

What`s New for 2023?

»Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.

»Global competitiveness and key competitor percentage market shares

» Market presence across multiple geographies - Strong/Active/Niche/Trivial

»Online interactive peer-to-peer collaborative bespoke updates

»Access to our digital archives and MarketGlass Research Platform

»Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Glufosinate Market to Reach $4.5 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Glufosinate estimated at US$2.4 Billion in the year 2022, is projected to reach a revised size of US$4.5 Billion by 2030, growing at aCAGR of 8% over the period 2022-2030. Genetically Modified, one of the segments analyzed in the report, is projected to record 8.4% CAGR and reach US$3.4 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Conventional segment is readjusted to a revised 6.8% CAGR for the next 8-year period.

The U.S. Market is Estimated at $646.5 Million, While China is Forecast to Grow at 11.8% CAGR

The Glufosinate market in the U.S. is estimated at US$646.5 Million in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.1 Billion by the year 2030 trailing a CAGR of 11.8% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.2% and 7.1% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 4.9% CAGR.

Select Competitors (Total 44 Featured) -

  • Bayer AG
  • Bayer CropScience AG
  • Dow, Inc.
  • DuPont de Nemours, Inc.
  • Jiangsu Huangma Agrochemicals Co., Ltd.
  • Jiangsu Sevencontinent Green Chemical Co., Ltd.
  • LIER Chemical Co., Ltd.
  • Nufarm Limited
  • Syngenta AG
  • UPL Ltd.
  • Veyong (Hebei Veyong Bio-Chemical Co. Ltd)

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Glufosinate - Global Key Competitors Percentage Market Share in 2022 (E)
    • Impact of Covid-19 and a Looming Global Recession
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Glufosinate by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Glufosinate by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 3: World 16-Year Perspective for Glufosinate by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2023 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Liquid Formulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Liquid Formulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 6: World 16-Year Perspective for Liquid Formulation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Dry Formulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Dry Formulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 9: World 16-Year Perspective for Dry Formulation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Agricultural by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Agricultural by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 12: World 16-Year Perspective for Agricultural by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 13: World Glufosinate Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Genetically Modified by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Genetically Modified by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 16: World 16-Year Perspective for Genetically Modified by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Conventional by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Conventional by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 19: World 16-Year Perspective for Conventional by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Non-Agricultural by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Non-Agricultural by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 22: World 16-Year Perspective for Non-Agricultural by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Glufosinate Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Glufosinate by Crop Type - Genetically Modified and Conventional - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Glufosinate by Crop Type - Genetically Modified and Conventional Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Glufosinate by Crop Type - Percentage Breakdown of Value Sales for Genetically Modified and Conventional for the Years 2014, 2023 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Glufosinate by Form - Liquid Formulation and Dry Formulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Glufosinate by Form - Liquid Formulation and Dry Formulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Glufosinate by Form - Percentage Breakdown of Value Sales for Liquid Formulation and Dry Formulation for the Years 2014, 2023 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Glufosinate by Application - Agricultural and Non-Agricultural - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Glufosinate by Application - Agricultural and Non-Agricultural Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Glufosinate by Application - Percentage Breakdown of Value Sales for Agricultural and Non-Agricultural for the Years 2014, 2023 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Glufosinate by Crop Type - Genetically Modified and Conventional - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Glufosinate by Crop Type - Genetically Modified and Conventional Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Glufosinate by Crop Type - Percentage Breakdown of Value Sales for Genetically Modified and Conventional for the Years 2014, 2023 & 2030
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Glufosinate by Form - Liquid Formulation and Dry Formulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Glufosinate by Form - Liquid Formulation and Dry Formulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 37: Canada 16-Year Perspective for Glufosinate by Form - Percentage Breakdown of Value Sales for Liquid Formulation and Dry Formulation for the Years 2014, 2023 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Glufosinate by Application - Agricultural and Non-Agricultural - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Glufosinate by Application - Agricultural and Non-Agricultural Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 40: Canada 16-Year Perspective for Glufosinate by Application - Percentage Breakdown of Value Sales for Agricultural and Non-Agricultural for the Years 2014, 2023 & 2030
  • JAPAN
    • Glufosinate Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Glufosinate by Crop Type - Genetically Modified and Conventional - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Glufosinate by Crop Type - Genetically Modified and Conventional Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 43: Japan 16-Year Perspective for Glufosinate by Crop Type - Percentage Breakdown of Value Sales for Genetically Modified and Conventional for the Years 2014, 2023 & 2030
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Glufosinate by Form - Liquid Formulation and Dry Formulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Glufosinate by Form - Liquid Formulation and Dry Formulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 46: Japan 16-Year Perspective for Glufosinate by Form - Percentage Breakdown of Value Sales for Liquid Formulation and Dry Formulation for the Years 2014, 2023 & 2030
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Glufosinate by Application - Agricultural and Non-Agricultural - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Glufosinate by Application - Agricultural and Non-Agricultural Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 49: Japan 16-Year Perspective for Glufosinate by Application - Percentage Breakdown of Value Sales for Agricultural and Non-Agricultural for the Years 2014, 2023 & 2030
  • CHINA
    • Glufosinate Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
    • TABLE 50: China Recent Past, Current & Future Analysis for Glufosinate by Crop Type - Genetically Modified and Conventional - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Glufosinate by Crop Type - Genetically Modified and Conventional Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 52: China 16-Year Perspective for Glufosinate by Crop Type - Percentage Breakdown of Value Sales for Genetically Modified and Conventional for the Years 2014, 2023 & 2030
    • TABLE 53: China Recent Past, Current & Future Analysis for Glufosinate by Form - Liquid Formulation and Dry Formulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 54: China Historic Review for Glufosinate by Form - Liquid Formulation and Dry Formulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 55: China 16-Year Perspective for Glufosinate by Form - Percentage Breakdown of Value Sales for Liquid Formulation and Dry Formulation for the Years 2014, 2023 & 2030
    • TABLE 56: China Recent Past, Current & Future Analysis for Glufosinate by Application - Agricultural and Non-Agricultural - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Glufosinate by Application - Agricultural and Non-Agricultural Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 58: China 16-Year Perspective for Glufosinate by Application - Percentage Breakdown of Value Sales for Agricultural and Non-Agricultural for the Years 2014, 2023 & 2030
  • EUROPE
    • Glufosinate Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Glufosinate by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Glufosinate by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 61: Europe 16-Year Perspective for Glufosinate by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2023 & 2030
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Glufosinate by Crop Type - Genetically Modified and Conventional - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Glufosinate by Crop Type - Genetically Modified and Conventional Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 64: Europe 16-Year Perspective for Glufosinate by Crop Type - Percentage Breakdown of Value Sales for Genetically Modified and Conventional for the Years 2014, 2023 & 2030
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Glufosinate by Form - Liquid Formulation and Dry Formulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Glufosinate by Form - Liquid Formulation and Dry Formulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 67: Europe 16-Year Perspective for Glufosinate by Form - Percentage Breakdown of Value Sales for Liquid Formulation and Dry Formulation for the Years 2014, 2023 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Glufosinate by Application - Agricultural and Non-Agricultural - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Glufosinate by Application - Agricultural and Non-Agricultural Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 70: Europe 16-Year Perspective for Glufosinate by Application - Percentage Breakdown of Value Sales for Agricultural and Non-Agricultural for the Years 2014, 2023 & 2030
  • FRANCE
    • Glufosinate Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
    • TABLE 71: France Recent Past, Current & Future Analysis for Glufosinate by Crop Type - Genetically Modified and Conventional - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 72: France Historic Review for Glufosinate by Crop Type - Genetically Modified and Conventional Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 73: France 16-Year Perspective for Glufosinate by Crop Type - Percentage Breakdown of Value Sales for Genetically Modified and Conventional for the Years 2014, 2023 & 2030
    • TABLE 74: France Recent Past, Current & Future Analysis for Glufosinate by Form - Liquid Formulation and Dry Formulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 75: France Historic Review for Glufosinate by Form - Liquid Formulation and Dry Formulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 76: France 16-Year Perspective for Glufosinate by Form - Percentage Breakdown of Value Sales for Liquid Formulation and Dry Formulation for the Years 2014, 2023 & 2030
    • TABLE 77: France Recent Past, Current & Future Analysis for Glufosinate by Application - Agricultural and Non-Agricultural - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 78: France Historic Review for Glufosinate by Application - Agricultural and Non-Agricultural Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 79: France 16-Year Perspective for Glufosinate by Application - Percentage Breakdown of Value Sales for Agricultural and Non-Agricultural for the Years 2014, 2023 & 2030
  • GERMANY
    • Glufosinate Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
    • TABLE 80: Germany Recent Past, Current & Future Analysis for Glufosinate by Crop Type - Genetically Modified and Conventional - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 81: Germany Historic Review for Glufosinate by Crop Type - Genetically Modified and Conventional Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 82: Germany 16-Year Perspective for Glufosinate by Crop Type - Percentage Breakdown of Value Sales for Genetically Modified and Conventional for the Years 2014, 2023 & 2030
    • TABLE 83: Germany Recent Past, Current & Future Analysis for Glufosinate by Form - Liquid Formulation and Dry Formulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 84: Germany Historic Review for Glufosinate by Form - Liquid Formulation and Dry Formulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 85: Germany 16-Year Perspective for Glufosinate by Form - Percentage Breakdown of Value Sales for Liquid Formulation and Dry Formulation for the Years 2014, 2023 & 2030
    • TABLE 86: Germany Recent Past, Current & Future Analysis for Glufosinate by Application - Agricultural and Non-Agricultural - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 87: Germany Historic Review for Glufosinate by Application - Agricultural and Non-Agricultural Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 88: Germany 16-Year Perspective for Glufosinate by Application - Percentage Breakdown of Value Sales for Agricultural and Non-Agricultural for the Years 2014, 2023 & 2030
  • ITALY
    • TABLE 89: Italy Recent Past, Current & Future Analysis for Glufosinate by Crop Type - Genetically Modified and Conventional - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 90: Italy Historic Review for Glufosinate by Crop Type - Genetically Modified and Conventional Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 91: Italy 16-Year Perspective for Glufosinate by Crop Type - Percentage Breakdown of Value Sales for Genetically Modified and Conventional for the Years 2014, 2023 & 2030
    • TABLE 92: Italy Recent Past, Current & Future Analysis for Glufosinate by Form - Liquid Formulation and Dry Formulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 93: Italy Historic Review for Glufosinate by Form - Liquid Formulation and Dry Formulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 94: Italy 16-Year Perspective for Glufosinate by Form - Percentage Breakdown of Value Sales for Liquid Formulation and Dry Formulation for the Years 2014, 2023 & 2030
    • TABLE 95: Italy Recent Past, Current & Future Analysis for Glufosinate by Application - Agricultural and Non-Agricultural - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 96: Italy Historic Review for Glufosinate by Application - Agricultural and Non-Agricultural Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 97: Italy 16-Year Perspective for Glufosinate by Application - Percentage Breakdown of Value Sales for Agricultural and Non-Agricultural for the Years 2014, 2023 & 2030
  • UNITED KINGDOM
    • Glufosinate Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
    • TABLE 98: UK Recent Past, Current & Future Analysis for Glufosinate by Crop Type - Genetically Modified and Conventional - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 99: UK Historic Review for Glufosinate by Crop Type - Genetically Modified and Conventional Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 100: UK 16-Year Perspective for Glufosinate by Crop Type - Percentage Breakdown of Value Sales for Genetically Modified and Conventional for the Years 2014, 2023 & 2030
    • TABLE 101: UK Recent Past, Current & Future Analysis for Glufosinate by Form - Liquid Formulation and Dry Formulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 102: UK Historic Review for Glufosinate by Form - Liquid Formulation and Dry Formulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 103: UK 16-Year Perspective for Glufosinate by Form - Percentage Breakdown of Value Sales for Liquid Formulation and Dry Formulation for the Years 2014, 2023 & 2030
    • TABLE 104: UK Recent Past, Current & Future Analysis for Glufosinate by Application - Agricultural and Non-Agricultural - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 105: UK Historic Review for Glufosinate by Application - Agricultural and Non-Agricultural Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 106: UK 16-Year Perspective for Glufosinate by Application - Percentage Breakdown of Value Sales for Agricultural and Non-Agricultural for the Years 2014, 2023 & 2030
  • SPAIN
    • TABLE 107: Spain Recent Past, Current & Future Analysis for Glufosinate by Crop Type - Genetically Modified and Conventional - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 108: Spain Historic Review for Glufosinate by Crop Type - Genetically Modified and Conventional Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 109: Spain 16-Year Perspective for Glufosinate by Crop Type - Percentage Breakdown of Value Sales for Genetically Modified and Conventional for the Years 2014, 2023 & 2030
    • TABLE 110: Spain Recent Past, Current & Future Analysis for Glufosinate by Form - Liquid Formulation and Dry Formulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 111: Spain Historic Review for Glufosinate by Form - Liquid Formulation and Dry Formulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 112: Spain 16-Year Perspective for Glufosinate by Form - Percentage Breakdown of Value Sales for Liquid Formulation and Dry Formulation for the Years 2014, 2023 & 2030
    • TABLE 113: Spain Recent Past, Current & Future Analysis for Glufosinate by Application - Agricultural and Non-Agricultural - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 114: Spain Historic Review for Glufosinate by Application - Agricultural and Non-Agricultural Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 115: Spain 16-Year Perspective for Glufosinate by Application - Percentage Breakdown of Value Sales for Agricultural and Non-Agricultural for the Years 2014, 2023 & 2030
  • RUSSIA
    • TABLE 116: Russia Recent Past, Current & Future Analysis for Glufosinate by Crop Type - Genetically Modified and Conventional - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 117: Russia Historic Review for Glufosinate by Crop Type - Genetically Modified and Conventional Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 118: Russia 16-Year Perspective for Glufosinate by Crop Type - Percentage Breakdown of Value Sales for Genetically Modified and Conventional for the Years 2014, 2023 & 2030
    • TABLE 119: Russia Recent Past, Current & Future Analysis for Glufosinate by Form - Liquid Formulation and Dry Formulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 120: Russia Historic Review for Glufosinate by Form - Liquid Formulation and Dry Formulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 121: Russia 16-Year Perspective for Glufosinate by Form - Percentage Breakdown of Value Sales for Liquid Formulation and Dry Formulation for the Years 2014, 2023 & 2030
    • TABLE 122: Russia Recent Past, Current & Future Analysis for Glufosinate by Application - Agricultural and Non-Agricultural - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 123: Russia Historic Review for Glufosinate by Application - Agricultural and Non-Agricultural Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 124: Russia 16-Year Perspective for Glufosinate by Application - Percentage Breakdown of Value Sales for Agricultural and Non-Agricultural for the Years 2014, 2023 & 2030
  • REST OF EUROPE
    • TABLE 125: Rest of Europe Recent Past, Current & Future Analysis for Glufosinate by Crop Type - Genetically Modified and Conventional - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 126: Rest of Europe Historic Review for Glufosinate by Crop Type - Genetically Modified and Conventional Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 127: Rest of Europe 16-Year Perspective for Glufosinate by Crop Type - Percentage Breakdown of Value Sales for Genetically Modified and Conventional for the Years 2014, 2023 & 2030
    • TABLE 128: Rest of Europe Recent Past, Current & Future Analysis for Glufosinate by Form - Liquid Formulation and Dry Formulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 129: Rest of Europe Historic Review for Glufosinate by Form - Liquid Formulation and Dry Formulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 130: Rest of Europe 16-Year Perspective for Glufosinate by Form - Percentage Breakdown of Value Sales for Liquid Formulation and Dry Formulation for the Years 2014, 2023 & 2030
    • TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Glufosinate by Application - Agricultural and Non-Agricultural - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 132: Rest of Europe Historic Review for Glufosinate by Application - Agricultural and Non-Agricultural Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 133: Rest of Europe 16-Year Perspective for Glufosinate by Application - Percentage Breakdown of Value Sales for Agricultural and Non-Agricultural for the Years 2014, 2023 & 2030
  • ASIA-PACIFIC
    • Glufosinate Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
    • TABLE 134: Asia-Pacific Recent Past, Current & Future Analysis for Glufosinate by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 135: Asia-Pacific Historic Review for Glufosinate by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 136: Asia-Pacific 16-Year Perspective for Glufosinate by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2023 & 2030
    • TABLE 137: Asia-Pacific Recent Past, Current & Future Analysis for Glufosinate by Crop Type - Genetically Modified and Conventional - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 138: Asia-Pacific Historic Review for Glufosinate by Crop Type - Genetically Modified and Conventional Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 139: Asia-Pacific 16-Year Perspective for Glufosinate by Crop Type - Percentage Breakdown of Value Sales for Genetically Modified and Conventional for the Years 2014, 2023 & 2030
    • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Glufosinate by Form - Liquid Formulation and Dry Formulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 141: Asia-Pacific Historic Review for Glufosinate by Form - Liquid Formulation and Dry Formulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 142: Asia-Pacific 16-Year Perspective for Glufosinate by Form - Percentage Breakdown of Value Sales for Liquid Formulation and Dry Formulation for the Years 2014, 2023 & 2030
    • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Glufosinate by Application - Agricultural and Non-Agricultural - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 144: Asia-Pacific Historic Review for Glufosinate by Application - Agricultural and Non-Agricultural Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 145: Asia-Pacific 16-Year Perspective for Glufosinate by Application - Percentage Breakdown of Value Sales for Agricultural and Non-Agricultural for the Years 2014, 2023 & 2030
  • AUSTRALIA
    • Glufosinate Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2023 (E)
    • TABLE 146: Australia Recent Past, Current & Future Analysis for Glufosinate by Crop Type - Genetically Modified and Conventional - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 147: Australia Historic Review for Glufosinate by Crop Type - Genetically Modified and Conventional Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 148: Australia 16-Year Perspective for Glufosinate by Crop Type - Percentage Breakdown of Value Sales for Genetically Modified and Conventional for the Years 2014, 2023 & 2030
    • TABLE 149: Australia Recent Past, Current & Future Analysis for Glufosinate by Form - Liquid Formulation and Dry Formulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 150: Australia Historic Review for Glufosinate by Form - Liquid Formulation and Dry Formulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 151: Australia 16-Year Perspective for Glufosinate by Form - Percentage Breakdown of Value Sales for Liquid Formulation and Dry Formulation for the Years 2014, 2023 & 2030
    • TABLE 152: Australia Recent Past, Current & Future Analysis for Glufosinate by Application - Agricultural and Non-Agricultural - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 153: Australia Historic Review for Glufosinate by Application - Agricultural and Non-Agricultural Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 154: Australia 16-Year Perspective for Glufosinate by Application - Percentage Breakdown of Value Sales for Agricultural and Non-Agricultural for the Years 2014, 2023 & 2030
  • INDIA
    • Glufosinate Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2023 (E)
    • TABLE 155: India Recent Past, Current & Future Analysis for Glufosinate by Crop Type - Genetically Modified and Conventional - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 156: India Historic Review for Glufosinate by Crop Type - Genetically Modified and Conventional Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 157: India 16-Year Perspective for Glufosinate by Crop Type - Percentage Breakdown of Value Sales for Genetically Modified and Conventional for the Years 2014, 2023 & 2030
    • TABLE 158: India Recent Past, Current & Future Analysis for Glufosinate by Form - Liquid Formulation and Dry Formulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 159: India Historic Review for Glufosinate by Form - Liquid Formulation and Dry Formulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 160: India 16-Year Perspective for Glufosinate by Form - Percentage Breakdown of Value Sales for Liquid Formulation and Dry Formulation for the Years 2014, 2023 & 2030
    • TABLE 161: India Recent Past, Current & Future Analysis for Glufosinate by Application - Agricultural and Non-Agricultural - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 162: India Historic Review for Glufosinate by Application - Agricultural and Non-Agricultural Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 163: India 16-Year Perspective for Glufosinate by Application - Percentage Breakdown of Value Sales for Agricultural and Non-Agricultural for the Years 2014, 2023 & 2030
  • SOUTH KOREA
    • TABLE 164: South Korea Recent Past, Current & Future Analysis for Glufosinate by Crop Type - Genetically Modified and Conventional - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 165: South Korea Historic Review for Glufosinate by Crop Type - Genetically Modified and Conventional Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 166: South Korea 16-Year Perspective for Glufosinate by Crop Type - Percentage Breakdown of Value Sales for Genetically Modified and Conventional for the Years 2014, 2023 & 2030
    • TABLE 167: South Korea Recent Past, Current & Future Analysis for Glufosinate by Form - Liquid Formulation and Dry Formulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 168: South Korea Historic Review for Glufosinate by Form - Liquid Formulation and Dry Formulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 169: South Korea 16-Year Perspective for Glufosinate by Form - Percentage Breakdown of Value Sales for Liquid Formulation and Dry Formulation for the Years 2014, 2023 & 2030
    • TABLE 170: South Korea Recent Past, Current & Future Analysis for Glufosinate by Application - Agricultural and Non-Agricultural - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 171: South Korea Historic Review for Glufosinate by Application - Agricultural and Non-Agricultural Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 172: South Korea 16-Year Perspective for Glufosinate by Application - Percentage Breakdown of Value Sales for Agricultural and Non-Agricultural for the Years 2014, 2023 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 173: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Glufosinate by Crop Type - Genetically Modified and Conventional - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 174: Rest of Asia-Pacific Historic Review for Glufosinate by Crop Type - Genetically Modified and Conventional Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 175: Rest of Asia-Pacific 16-Year Perspective for Glufosinate by Crop Type - Percentage Breakdown of Value Sales for Genetically Modified and Conventional for the Years 2014, 2023 & 2030
    • TABLE 176: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Glufosinate by Form - Liquid Formulation and Dry Formulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 177: Rest of Asia-Pacific Historic Review for Glufosinate by Form - Liquid Formulation and Dry Formulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 178: Rest of Asia-Pacific 16-Year Perspective for Glufosinate by Form - Percentage Breakdown of Value Sales for Liquid Formulation and Dry Formulation for the Years 2014, 2023 & 2030
    • TABLE 179: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Glufosinate by Application - Agricultural and Non-Agricultural - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 180: Rest of Asia-Pacific Historic Review for Glufosinate by Application - Agricultural and Non-Agricultural Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 181: Rest of Asia-Pacific 16-Year Perspective for Glufosinate by Application - Percentage Breakdown of Value Sales for Agricultural and Non-Agricultural for the Years 2014, 2023 & 2030
  • LATIN AMERICA
    • Glufosinate Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2023 (E)
    • TABLE 182: Latin America Recent Past, Current & Future Analysis for Glufosinate by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 183: Latin America Historic Review for Glufosinate by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 184: Latin America 16-Year Perspective for Glufosinate by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2023 & 2030
    • TABLE 185: Latin America Recent Past, Current & Future Analysis for Glufosinate by Crop Type - Genetically Modified and Conventional - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 186: Latin America Historic Review for Glufosinate by Crop Type - Genetically Modified and Conventional Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 187: Latin America 16-Year Perspective for Glufosinate by Crop Type - Percentage Breakdown of Value Sales for Genetically Modified and Conventional for the Years 2014, 2023 & 2030
    • TABLE 188: Latin America Recent Past, Current & Future Analysis for Glufosinate by Form - Liquid Formulation and Dry Formulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 189: Latin America Historic Review for Glufosinate by Form - Liquid Formulation and Dry Formulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 190: Latin America 16-Year Perspective for Glufosinate by Form - Percentage Breakdown of Value Sales for Liquid Formulation and Dry Formulation for the Years 2014, 2023 & 2030
    • TABLE 191: Latin America Recent Past, Current & Future Analysis for Glufosinate by Application - Agricultural and Non-Agricultural - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 192: Latin America Historic Review for Glufosinate by Application - Agricultural and Non-Agricultural Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 193: Latin America 16-Year Perspective for Glufosinate by Application - Percentage Breakdown of Value Sales for Agricultural and Non-Agricultural for the Years 2014, 2023 & 2030
  • ARGENTINA
    • TABLE 194: Argentina Recent Past, Current & Future Analysis for Glufosinate by Crop Type - Genetically Modified and Conventional - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 195: Argentina Historic Review for Glufosinate by Crop Type - Genetically Modified and Conventional Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 196: Argentina 16-Year Perspective for Glufosinate by Crop Type - Percentage Breakdown of Value Sales for Genetically Modified and Conventional for the Years 2014, 2023 & 2030
    • TABLE 197: Argentina Recent Past, Current & Future Analysis for Glufosinate by Form - Liquid Formulation and Dry Formulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 198: Argentina Historic Review for Glufosinate by Form - Liquid Formulation and Dry Formulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 199: Argentina 16-Year Perspective for Glufosinate by Form - Percentage Breakdown of Value Sales for Liquid Formulation and Dry Formulation for the Years 2014, 2023 & 2030
    • TABLE 200: Argentina Recent Past, Current & Future Analysis for Glufosinate by Application - Agricultural and Non-Agricultural - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 201: Argentina Historic Review for Glufosinate by Application - Agricultural and Non-Agricultural Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 202: Argentina 16-Year Perspective for Glufosinate by Application - Percentage Breakdown of Value Sales for Agricultural and Non-Agricultural for the Years 2014, 2023 & 2030
  • BRAZIL
    • TABLE 203: Brazil Recent Past, Current & Future Analysis for Glufosinate by Crop Type - Genetically Modified and Conventional - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 204: Brazil Historic Review for Glufosinate by Crop Type - Genetically Modified and Conventional Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 205: Brazil 16-Year Perspective for Glufosinate by Crop Type - Percentage Breakdown of Value Sales for Genetically Modified and Conventional for the Years 2014, 2023 & 2030
    • TABLE 206: Brazil Recent Past, Current & Future Analysis for Glufosinate by Form - Liquid Formulation and Dry Formulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 207: Brazil Historic Review for Glufosinate by Form - Liquid Formulation and Dry Formulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 208: Brazil 16-Year Perspective for Glufosinate by Form - Percentage Breakdown of Value Sales for Liquid Formulation and Dry Formulation for the Years 2014, 2023 & 2030
    • TABLE 209: Brazil Recent Past, Current & Future Analysis for Glufosinate by Application - Agricultural and Non-Agricultural - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 210: Brazil Historic Review for Glufosinate by Application - Agricultural and Non-Agricultural Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 211: Brazil 16-Year Perspective for Glufosinate by Application - Percentage Breakdown of Value Sales for Agricultural and Non-Agricultural for the Years 2014, 2023 & 2030
  • MEXICO
    • TABLE 212: Mexico Recent Past, Current & Future Analysis for Glufosinate by Crop Type - Genetically Modified and Conventional - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 213: Mexico Historic Review for Glufosinate by Crop Type - Genetically Modified and Conventional Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 214: Mexico 16-Year Perspective for Glufosinate by Crop Type - Percentage Breakdown of Value Sales for Genetically Modified and Conventional for the Years 2014, 2023 & 2030
    • TABLE 215: Mexico Recent Past, Current & Future Analysis for Glufosinate by Form - Liquid Formulation and Dry Formulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 216: Mexico Historic Review for Glufosinate by Form - Liquid Formulation and Dry Formulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 217: Mexico 16-Year Perspective for Glufosinate by Form - Percentage Breakdown of Value Sales for Liquid Formulation and Dry Formulation for the Years 2014, 2023 & 2030
    • TABLE 218: Mexico Recent Past, Current & Future Analysis for Glufosinate by Application - Agricultural and Non-Agricultural - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 219: Mexico Historic Review for Glufosinate by Application - Agricultural and Non-Agricultural Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 220: Mexico 16-Year Perspective for Glufosinate by Application - Percentage Breakdown of Value Sales for Agricultural and Non-Agricultural for the Years 2014, 2023 & 2030
  • REST OF LATIN AMERICA
    • TABLE 221: Rest of Latin America Recent Past, Current & Future Analysis for Glufosinate by Crop Type - Genetically Modified and Conventional - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 222: Rest of Latin America Historic Review for Glufosinate by Crop Type - Genetically Modified and Conventional Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 223: Rest of Latin America 16-Year Perspective for Glufosinate by Crop Type - Percentage Breakdown of Value Sales for Genetically Modified and Conventional for the Years 2014, 2023 & 2030
    • TABLE 224: Rest of Latin America Recent Past, Current & Future Analysis for Glufosinate by Form - Liquid Formulation and Dry Formulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 225: Rest of Latin America Historic Review for Glufosinate by Form - Liquid Formulation and Dry Formulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 226: Rest of Latin America 16-Year Perspective for Glufosinate by Form - Percentage Breakdown of Value Sales for Liquid Formulation and Dry Formulation for the Years 2014, 2023 & 2030
    • TABLE 227: Rest of Latin America Recent Past, Current & Future Analysis for Glufosinate by Application - Agricultural and Non-Agricultural - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 228: Rest of Latin America Historic Review for Glufosinate by Application - Agricultural and Non-Agricultural Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 229: Rest of Latin America 16-Year Perspective for Glufosinate by Application - Percentage Breakdown of Value Sales for Agricultural and Non-Agricultural for the Years 2014, 2023 & 2030
  • MIDDLE EAST
    • Glufosinate Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2023 (E)
    • TABLE 230: Middle East Recent Past, Current & Future Analysis for Glufosinate by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 231: Middle East Historic Review for Glufosinate by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 232: Middle East 16-Year Perspective for Glufosinate by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2023 & 2030
    • TABLE 233: Middle East Recent Past, Current & Future Analysis for Glufosinate by Crop Type - Genetically Modified and Conventional - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 234: Middle East Historic Review for Glufosinate by Crop Type - Genetically Modified and Conventional Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 235: Middle East 16-Year Perspective for Glufosinate by Crop Type - Percentage Breakdown of Value Sales for Genetically Modified and Conventional for the Years 2014, 2023 & 2030
    • TABLE 236: Middle East Recent Past, Current & Future Analysis for Glufosinate by Form - Liquid Formulation and Dry Formulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 237: Middle East Historic Review for Glufosinate by Form - Liquid Formulation and Dry Formulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 238: Middle East 16-Year Perspective for Glufosinate by Form - Percentage Breakdown of Value Sales for Liquid Formulation and Dry Formulation for the Years 2014, 2023 & 2030
    • TABLE 239: Middle East Recent Past, Current & Future Analysis for Glufosinate by Application - Agricultural and Non-Agricultural - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 240: Middle East Historic Review for Glufosinate by Application - Agricultural and Non-Agricultural Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 241: Middle East 16-Year Perspective for Glufosinate by Application - Percentage Breakdown of Value Sales for Agricultural and Non-Agricultural for the Years 2014, 2023 & 2030
  • IRAN
    • TABLE 242: Iran Recent Past, Current & Future Analysis for Glufosinate by Crop Type - Genetically Modified and Conventional - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 243: Iran Historic Review for Glufosinate by Crop Type - Genetically Modified and Conventional Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 244: Iran 16-Year Perspective for Glufosinate by Crop Type - Percentage Breakdown of Value Sales for Genetically Modified and Conventional for the Years 2014, 2023 & 2030
    • TABLE 245: Iran Recent Past, Current & Future Analysis for Glufosinate by Form - Liquid Formulation and Dry Formulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 246: Iran Historic Review for Glufosinate by Form - Liquid Formulation and Dry Formulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 247: Iran 16-Year Perspective for Glufosinate by Form - Percentage Breakdown of Value Sales for Liquid Formulation and Dry Formulation for the Years 2014, 2023 & 2030
    • TABLE 248: Iran Recent Past, Current & Future Analysis for Glufosinate by Application - Agricultural and Non-Agricultural - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 249: Iran Historic Review for Glufosinate by Application - Agricultural and Non-Agricultural Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 250: Iran 16-Year Perspective for Glufosinate by Application - Percentage Breakdown of Value Sales for Agricultural and Non-Agricultural for the Years 2014, 2023 & 2030
  • ISRAEL
    • TABLE 251: Israel Recent Past, Current & Future Analysis for Glufosinate by Crop Type - Genetically Modified and Conventional - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 252: Israel Historic Review for Glufosinate by Crop Type - Genetically Modified and Conventional Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 253: Israel 16-Year Perspective for Glufosinate by Crop Type - Percentage Breakdown of Value Sales for Genetically Modified and Conventional for the Years 2014, 2023 & 2030
    • TABLE 254: Israel Recent Past, Current & Future Analysis for Glufosinate by Form - Liquid Formulation and Dry Formulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 255: Israel Historic Review for Glufosinate by Form - Liquid Formulation and Dry Formulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 256: Israel 16-Year Perspective for Glufosinate by Form - Percentage Breakdown of Value Sales for Liquid Formulation and Dry Formulation for the Years 2014, 2023 & 2030
    • TABLE 257: Israel Recent Past, Current & Future Analysis for Glufosinate by Application - Agricultural and Non-Agricultural - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 258: Israel Historic Review for Glufosinate by Application - Agricultural and Non-Agricultural Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 259: Israel 16-Year Perspective for Glufosinate by Application - Percentage Breakdown of Value Sales for Agricultural and Non-Agricultural for the Years 2014, 2023 & 2030
  • SAUDI ARABIA
    • TABLE 260: Saudi Arabia Recent Past, Current & Future Analysis for Glufosinate by Crop Type - Genetically Modified and Conventional - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 261: Saudi Arabia Historic Review for Glufosinate by Crop Type - Genetically Modified and Conventional Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 262: Saudi Arabia 16-Year Perspective for Glufosinate by Crop Type - Percentage Breakdown of Value Sales for Genetically Modified and Conventional for the Years 2014, 2023 & 2030
    • TABLE 263: Saudi Arabia Recent Past, Current & Future Analysis for Glufosinate by Form - Liquid Formulation and Dry Formulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 264: Saudi Arabia Historic Review for Glufosinate by Form - Liquid Formulation and Dry Formulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 265: Saudi Arabia 16-Year Perspective for Glufosinate by Form - Percentage Breakdown of Value Sales for Liquid Formulation and Dry Formulation for the Years 2014, 2023 & 2030
    • TABLE 266: Saudi Arabia Recent Past, Current & Future Analysis for Glufosinate by Application - Agricultural and Non-Agricultural - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 267: Saudi Arabia Historic Review for Glufosinate by Application - Agricultural and Non-Agricultural Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 268: Saudi Arabia 16-Year Perspective for Glufosinate by Application - Percentage Breakdown of Value Sales for Agricultural and Non-Agricultural for the Years 2014, 2023 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 269: UAE Recent Past, Current & Future Analysis for Glufosinate by Crop Type - Genetically Modified and Conventional - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 270: UAE Historic Review for Glufosinate by Crop Type - Genetically Modified and Conventional Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 271: UAE 16-Year Perspective for Glufosinate by Crop Type - Percentage Breakdown of Value Sales for Genetically Modified and Conventional for the Years 2014, 2023 & 2030
    • TABLE 272: UAE Recent Past, Current & Future Analysis for Glufosinate by Form - Liquid Formulation and Dry Formulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 273: UAE Historic Review for Glufosinate by Form - Liquid Formulation and Dry Formulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 274: UAE 16-Year Perspective for Glufosinate by Form - Percentage Breakdown of Value Sales for Liquid Formulation and Dry Formulation for the Years 2014, 2023 & 2030
    • TABLE 275: UAE Recent Past, Current & Future Analysis for Glufosinate by Application - Agricultural and Non-Agricultural - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 276: UAE Historic Review for Glufosinate by Application - Agricultural and Non-Agricultural Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 277: UAE 16-Year Perspective for Glufosinate by Application - Percentage Breakdown of Value Sales for Agricultural and Non-Agricultural for the Years 2014, 2023 & 2030
  • REST OF MIDDLE EAST
    • TABLE 278: Rest of Middle East Recent Past, Current & Future Analysis for Glufosinate by Crop Type - Genetically Modified and Conventional - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 279: Rest of Middle East Historic Review for Glufosinate by Crop Type - Genetically Modified and Conventional Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 280: Rest of Middle East 16-Year Perspective for Glufosinate by Crop Type - Percentage Breakdown of Value Sales for Genetically Modified and Conventional for the Years 2014, 2023 & 2030
    • TABLE 281: Rest of Middle East Recent Past, Current & Future Analysis for Glufosinate by Form - Liquid Formulation and Dry Formulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 282: Rest of Middle East Historic Review for Glufosinate by Form - Liquid Formulation and Dry Formulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 283: Rest of Middle East 16-Year Perspective for Glufosinate by Form - Percentage Breakdown of Value Sales for Liquid Formulation and Dry Formulation for the Years 2014, 2023 & 2030
    • TABLE 284: Rest of Middle East Recent Past, Current & Future Analysis for Glufosinate by Application - Agricultural and Non-Agricultural - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 285: Rest of Middle East Historic Review for Glufosinate by Application - Agricultural and Non-Agricultural Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 286: Rest of Middle East 16-Year Perspective for Glufosinate by Application - Percentage Breakdown of Value Sales for Agricultural and Non-Agricultural for the Years 2014, 2023 & 2030
  • AFRICA
    • Glufosinate Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2023 (E)
    • TABLE 287: Africa Recent Past, Current & Future Analysis for Glufosinate by Crop Type - Genetically Modified and Conventional - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 288: Africa Historic Review for Glufosinate by Crop Type - Genetically Modified and Conventional Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 289: Africa 16-Year Perspective for Glufosinate by Crop Type - Percentage Breakdown of Value Sales for Genetically Modified and Conventional for the Years 2014, 2023 & 2030
    • TABLE 290: Africa Recent Past, Current & Future Analysis for Glufosinate by Form - Liquid Formulation and Dry Formulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 291: Africa Historic Review for Glufosinate by Form - Liquid Formulation and Dry Formulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 292: Africa 16-Year Perspective for Glufosinate by Form - Percentage Breakdown of Value Sales for Liquid Formulation and Dry Formulation for the Years 2014, 2023 & 2030
    • TABLE 293: Africa Recent Past, Current & Future Analysis for Glufosinate by Application - Agricultural and Non-Agricultural - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 294: Africa Historic Review for Glufosinate by Application - Agricultural and Non-Agricultural Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 295: Africa 16-Year Perspective for Glufosinate by Application - Percentage Breakdown of Value Sales for Agricultural and Non-Agricultural for the Years 2014, 2023 & 2030

IV. COMPETITION